Presidio Property Trust, Inc. (SQFTW)
| Previous close | 0.0368 |
| Open | 0.0440 |
| Bid | 0.0265 x 1300 |
| Ask | 0.0390 x 1000 |
| Day's range | 0.0340 - 0.0440 |
| 52-week range | 0.0340 - 0.0440 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Presidio Property Trust Declares Third-Quarter 2023 Dividend
Board of Directors approves cash dividend of $0.023 per shareSAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: SQFT; SQFTP) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust (“REIT”), today announced that its Board of Directors has authorized a cash dividend of $0.023 per share on its Series A Common Stock for the third quarter of 2023. The dividend will be payable on October 11, 2023, to all stockholders of record a
- GlobeNewswire
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose acquisition company (Nasdaq: MURF) (“MURF”), announced today the completion of the previously announced business combination (the “Transaction”). Conduit expects to commence trading on September 25, 2023, under ticke
- GlobeNewswire
Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives
SAN DIEGO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (Nasdaq: SQFT, SQFTP) (the “Company”), an internally managed, diversified real estate investment trust (“REIT”), today announced that its Board of Directors (the “Board”) has established a Special Committee of the Board (the “Special Committee”) to explore potential strategic alternatives focusing on maximizing stockholder value. The Special Committee is comprised solely of independent directors and is charged with explo
